Close

Brean Murray Carret & Co. maintains a 'Buy' on Regeneron Pharma (REGN); Adjusting Eylea Sales Upward Jan 10, 2012 12:03PM
Brean Murray Carret & Co. Maintains a 'Buy' on Regeneron Pharma (REGN); Royalty Obligation To Roche Not So Bad Thus Far Jan 3, 2012 12:56PM
Brean Murray Carret Cuts Price Target on Regeneron Pharma (REGN) Following Two Year Phase 3 Results Comparing Eylea with Lucentis Dec 5, 2011 10:58AM
Notable Analyst Rating Changes 10/26: (AMTD) (NFLX) (REGN) Upgraded; (HGSI) (FSLR) (MF) Downgraded Oct 26, 2011 11:22AM
Notable 52-Week Highs and Lows of the Day 09/21: (REGN) (OPTR) (RRC) High; (ANR) (WLT) (MS) Low Sep 21, 2011 03:15PM


Sep 9, 2011 11:07AM Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
Apr 29, 2011 10:42AM Morning Movers 04/29: (SPWRA) (NTGR) (ACOM) (ASGN) Higher; (KVHI) (SUNH) (KND) (RIMM) Lower
Apr 28, 2011 10:05AM Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Yesterdays Announcment on Phase 3 GALILEO Trial
Apr 27, 2011 09:51AM Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Yesterdays Announcment on Zaltrap
Apr 18, 2011 11:08AM Brean Murray Carret & Co. Raises Price Target on Regeneron Pharma (REGN) Following Priority Review Rating for VEGF Trap Eye
Nov 23, 2010 10:28AM Canaccord Genuity Morning Coffee on Regeneron Pharma (REGN): Stick a Needle in My Eye
Oct 8, 2010 09:40AM Brean Murray Initiates Coverage on Regeneron Pharmaceuticals (REGN) with a Buy; Results of Phase 3 Trials to Add Substantial Value